EN Contact sales
bioseutica®, the 1st choice for food, pharma and feed ingredients
Gloved hand holding a cell-culture plate in a laboratory

The Group

History of the Group

Milestones since 1947, production and extraction sites, and the countries we serve.

Our history and footprint

Milestones since 1947, production and extraction sites, and the countries we serve. Select a figure.

  1. Rodolfo Ferrari and Carlo Callerio found the Italian company SPA (Società Prodotti Antibiotici) to manufacture penicillin and lysozyme.

  2. SPA and Sir Alexander Fleming collaborate to develop large-scale production of penicillin and lysozyme.

  3. SPA establishes the first industrial-scale lysozyme plant at NIVE in Nunspeet, The Netherlands.

  4. SPA establishes Fordras SA in Lugano, Switzerland, for worldwide sales of lysozyme API and for R&D.

  5. Canadian company Neova Technologies starts lysozyme production in Zeewolde, The Netherlands, and begins working with Kaken on the new polyene amcipatricin.

  6. Fordras SA is spun off from SPA; LMC B.V. starts production of lysozyme API and of the amcipatricin molecule.

  7. Fordras SA and Neova Technologies Inc. merge under bioseutica® B.V.

  8. Egg white extraction is consolidated in The Netherlands, pancreatic enzymes in Canada.

  9. New products are developed: NA2R® (2014), Entegard® (2018) and AVIFORT™ (2018).

  10. Acquisition of Belovo, Belgium, from BNL Food Group.

  11. bioseutica® Fordras SA launches its first consumer product, LYSOGUARD immune®.

  12. bioseutica® opens a new lysozyme plant in Ospel, The Netherlands, and celebrates 100 years of lysozyme in Lugano with international guests and customers.

  13. bioseutica® establishes new production plants in Asia.

Production sites

Manufacturing in Europe, Canada and Asia.

  • Zeewolde, The Netherlandsbioseutica® B.V., lysozyme and egg white proteins
  • Ospel, The NetherlandsLysozyme plant, opened in 2022
  • Bastogne, Belgiumbioseutica® SRL (formerly Belovo), acquired in 2017
  • Abbotsford, CanadaNeova Technologies Inc., egg proteins and pancreatic enzymes
  • [Asia, plants established in 2024][Town, country, activity]
  • [Production site 6][Town, country, activity]
  • [Production site 7][Town, country, activity]

Extraction sites

Egg white extraction in The Netherlands, pancreatic enzymes in Canada (since 2011).

  • [Zeewolde], The NetherlandsHen egg white [site to be confirmed]
  • Abbotsford, CanadaPorcine pancreas: pancreatic enzymes
  • [Extraction site][Marine raw materials]

Countries served

Customers in 30 countries. [Sample list, to be confirmed]

  • Europe 18

    • Netherlands
    • Belgium
    • Germany
    • France
    • Italy
    • Spain
    • Portugal
    • Switzerland
    • Austria
    • United Kingdom
    • Ireland
    • Denmark
    • Sweden
    • Norway
    • Finland
    • Poland
    • Czechia
    • Greece

  • Americas 6

    • United States
    • Canada
    • Mexico
    • Brazil
    • Argentina
    • Chile

  • Asia and Pacific 5

    • Japan
    • South Korea
    • China
    • India
    • Australia

  • Africa 1

    • South Africa

Milestones

From SPA in 1947 to new plants in Asia.

  1. Rodolfo Ferrari and Carlo Callerio found the Italian company SPA (Società Prodotti Antibiotici) to manufacture penicillin and lysozyme.

  2. SPA and Sir Alexander Fleming collaborate to develop large-scale production of penicillin and lysozyme.

  3. SPA establishes the first industrial-scale lysozyme plant at NIVE in Nunspeet, The Netherlands.

  4. SPA establishes Fordras SA in Lugano, Switzerland, for worldwide sales of lysozyme API and for R&D.

  5. Canadian company Neova Technologies starts lysozyme production in Zeewolde, The Netherlands, and begins working with Kaken on the new polyene amcipatricin.

  6. Fordras SA is spun off from SPA; LMC B.V. starts production of lysozyme API and of the amcipatricin molecule.

  7. Fordras SA and Neova Technologies Inc. merge under bioseutica® B.V.

  8. Egg white extraction is consolidated in The Netherlands, pancreatic enzymes in Canada.

  9. New products are developed: NA2R® (2014), Entegard® (2018) and AVIFORT™ (2018).

  10. Acquisition of Belovo, Belgium, from BNL Food Group.

  11. bioseutica® Fordras SA launches its first consumer product, LYSOGUARD immune®.

  12. bioseutica® opens a new lysozyme plant in Ospel, The Netherlands, and celebrates 100 years of lysozyme in Lugano with international guests and customers.

  13. bioseutica® establishes new production plants in Asia.